Staphylococcus aureus clumping factor B mediates biofilm formation in the absence of calcium
Open Access
- 1 June 2012
- journal article
- Published by Microbiology Society in Microbiology
- Vol. 158 (6) , 1504-1512
Abstract
Staphylococcus aureus is the leading cause of nosocomial infections and a major cause of community-acquired infections. Biofilm formation is a key virulence determinant in certain types of S. aureus infection, especially those involving inserted medical devices. We found in a previous study that the calcium chelators sodium citrate and EGTA inhibit biofilm formation in certain strains of S. aureus but actually augment biofilm formation in other strains. Even two closely related strains, Newman and 10833, exhibited strikingly different biofilm phenotypes in the presence of calcium chelators, in that biofilm formation was inhibited in Newman but augmented in 10833. We also found that the surface protein clumping factor B (ClfB) plays a role in this phenomenon. In this study, we confirm that ClfB is required for biofilm formation under calcium-depleted conditions. We investigated the post-translational regulation of ClfB-mediated biofilm formation and found evidence that both calcium and the protease aureolysin disrupt established ClfB-dependent biofilms. Finally, we investigated the genetic basis for the biofilm-negative phenotype in strain Newman versus the biofilm-positive phenotype in strain 10833 under calcium-depleted conditions and found that strain 10833 contains a deletion that results in a stop codon within the aureolysin gene (aur). When 10833 expressed Newman aur, surface-associated ClfB and the ability to form a biofilm in chelating conditions was lost. Thus, the positive effect of chelating agents on biofilm formation in certain strains can be explained by increased ClfB activity in the absence of calcium and the discrepancy in the response of strains 10833 and Newman can be explained by point mutations in aur. This study reveals a previously unknown, to our knowledge, role for ClfB in biofilm formation and underscores the potential for striking phenotypic variability resulting from minor differences in strain background.Keywords
This publication has 27 references indexed in Scilit:
- Guidelines for the prevention of intravascular catheter-related infectionsAmerican Journal of Infection Control, 2011
- Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: More than 0.5 million catheter days and 7 years of clinical experience*Critical Care Medicine, 2011
- Analytic Reviews: Prevention of Central Venous Catheter Bloodstream InfectionsJournal of Intensive Care Medicine, 2010
- Epidemic community-associated methicillin-resistant Staphylococcus aureus : Recent clonal expansion and diversificationProceedings of the National Academy of Sciences, 2008
- Both Complement- and Fibrinogen-Dependent Mechanisms Contribute to Platelet Aggregation Mediated by Staphylococcus aureus Clumping Factor BInfection and Immunity, 2007
- Staphylococcus aureusclumping factor B (ClfB) promotes adherence to human type I cytokeratin 10: implications for nasal colonizationCellular Microbiology, 2002
- Structural Organization of the Fibrinogen-binding Region of the Clumping Factor B MSCRAMM of Staphylococcus aureusJournal of Biological Chemistry, 2001
- Contribution of Clumping Factor B to Pathogenesis of Experimental Endocarditis due to Staphylococcus aureusInfection and Immunity, 2000
- The toxic shock syndrome exotoxin structural gene is not detectably transmitted by a prophageNature, 1983
- NATURE OF THE DETERMINANT OF TETRACYCLINE RESISTANCE IN STAPHYLOCOCCUS AUREUSCanadian Journal of Microbiology, 1967